Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • Communities & Collections
  • Research Outputs
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Department of Medicine
  4. Department of Medicine (up to 2019)
  5. The increasing genetic diversity of HIV-1 in the UK, 2002-2010
 
  • Details
The increasing genetic diversity of HIV-1 in the UK, 2002-2010
File(s)
The increasing genetic diversity of HIV-1 in the UK, 2002-2010.pdf (1.21 MB)
Published version
Author(s)
Dunn, David
Type
Journal Article
Abstract
Objective: HIV-1 is typically categorized by genetically distinct viral subtypes. Viral subtypes are usually compartmentalized by ethnicity and transmission group and, thus, convey important epidemiological information, as well as possibly influencing the rate of disease progression. We aim to describe the prevalence and time trends of subtypes observed among key populations living with HIV-1 in the UK.

Design: Analyses of reverse transcriptase and protease sequences generated from HIV-1-positive antiretroviral-naive patients as part of routine resistance testing between 2002 and 2010 in all public health and NHS laboratories in the UK.

Methods: Subtype was assigned centrally using the SCUEAL algorithm. Subtyping results were combined with data from the UK Collaborative HIV Cohort Study and the UK HIV and AIDS Reporting System. Analyses adjusted for the number of national HIV-1 diagnoses made each year within demographic subgroups. Viral subtypes were described overall, over time and by demographic subgroup.

Results: Subtype B diagnoses (39.9%) have remained stable since 2005, whereas subtype C diagnoses (34.3%) were found to decline in prevalence from 2004. Across most demographic subgroups, the prevalence of non-B non-C subtypes has increased over time, in particular novel recombinant forms (9.9%), subtype G (2.7%), and CRF01 AE (2.0%).

Conclusion: HIV-1 subtypes are increasingly represented across all demographic subgroups and this could be evidence of sexual mixing. Between 2002 and 2010, the prevalence of novel recombinant forms has increased in all demographic subgroups. This increasing genetic diversity and the effect of subtype on disease progression may impact future HIV-1 treatment and prevention.
Date Issued
2014-03-13
Date Acceptance
2013-10-18
Citation
AIDS, 2014, 28 (5), pp.773-780
URI
http://hdl.handle.net/10044/1/69396
DOI
https://www.dx.doi.org/10.1097/QAD.0000000000000119
ISSN
0269-9370
Publisher
Lippincott, Williams & Wilkins
Start Page
773
End Page
780
Journal / Book Title
AIDS
Volume
28
Issue
5
Copyright Statement
© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License (https://creativecommons.org/licenses/by-nc-nd/3.0/) , where it is permissible to download and share the work
provided it is properly cited. The work cannot be changed in any way or used commercially.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333386700015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Virology
HIV-1
epidemiology
subtyping
UK
subtype
genetic diversity
IMMUNODEFICIENCY-VIRUS TYPE-1
NON-B SUBTYPES
ANTIRETROVIRAL THERAPY
SURVEILLANCE
INDIVIDUALS
HETEROSEXUALS
GUIDELINES
SEQUENCES
EUROPE
TOOLS
Publication Status
Published
Date Publish Online
2014-03-13
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback